Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| West-Ward Columbus Inc. | Columbus, OH, United States | Makes it | No problems foundApr 30, 2026 · 27 inspections |
Recalls
- Dec 22, 2016 · Class II · Roxane Laboratories, Inc.
Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.
Lots: Lot# 660833A, Exp 08/31/18 - Sep 25, 2015 · Class III · Boehringer Ingelheim Roxane Inc
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Lots: Lot #: 559660P, 559661P, Exp 03/17 - Sep 25, 2015 · Class III · Boehringer Ingelheim Roxane Inc
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Lots: Lot #: 559310P, Exp 02/17; 559664B, Exp 04/17
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Furosemide: every company that makes it
- Form
- solution, oral
- Strength
- 10 mg per 1 mL
- Approval
- ANDA ANDA070434
- On the market since
- Jul 12, 1988
- Package NDCs
0054-3294-460054-3294-50- Official label
- DailyMed (National Library of Medicine), updated Nov 3, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?